DAA use decreases risk for cardiovascular events in patients with advanced fibrosis, HCV - Healio

LONDON — Direct-acting antiviral treatment correlated with a decreased risk for cardiovascular outcomes among patients with hepatitis C virus and advanced fibrosis but an increased risk for arrhythmias and conduction disorders. “Several studies ha…

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.Back to Healio LONDON — Direct-acting antiviral treatme… [+1977 chars]

full article...